AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...
Enterprise technology news and analysis UK lawmakers back licensing‑first approach, adding pressure to global AI copyright standards Enterprises procuring AI tools may soon need to verify whether the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results